Volume 8, Number 3—March 2002
Synopsis
Human Campylobacteriosis in Developing Countries1
Akitoye O. Coker*
, Raphael D. Isokpehi*, Bolaji N. Thomas*, Kehinde O. Amisu*, and C. Larry Obi†
, Raphael D. Isokpehi*, Bolaji N. Thomas*, Kehinde O. Amisu*, and C. Larry Obi†
Table 1
Isolation rates of Campylobacter from diarrhea specimens from <5-year-olds in selected developing countries
| WHO region and country | Isolation rate (%) | Reference |
|---|---|---|
| Africa | ||
| Algeria | 17.7 | 14 |
| Cameroon | 7.7 | 15 |
| Ethiopia | 13.8 | 16 |
| Nigeria | 16.5 | 17 |
| Tanzania | 18.0 | 18 |
| Zimbabwe | 9.3 | 19 |
| Americas | ||
| Brazil | 9.9 | 20 |
| Guatemala | 12.1 | 21 |
| Eastern Mediterranean | ||
| Egypt | 9.0 | 12 |
| Jordan | 5.5 | 22 |
| Southeast Asia | ||
| Bangladesh | 17.4 | 23 |
| Thailand | 13.0 | 24 |
| Western Pacific | ||
| Laos | 12.1 | 25 |
WHO = World Health Organization.
1 Portions of this review were presented at the World Health Organization Consultation on the Increasing Incidence of Campylobacteriosis in Humans, Copenhagen, Denmark, November 1-25, 2000. In addition, relevant emerging information from the 11th International Workshop on Campylobacter, Helicobacter and Related Organisms, held in Freiburg, Germany, September 1-5, 2001, are included.
Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential